Thyroid eye disease (TED) is a complex autoimmune disorder and the most common extrathyroidal manifestation of Graves' disease, characterized by orbital inflammation, tissue remodelling, and varying degrees of functional and cosmetic impairment. Although often mild, moderate-to-severe and sight-threatening forms can significantly compromise vision and quality of life....
✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change for audiologists or hearing specialists; this article is outside the scope of audiology entirely.
✦ Why It Matters ✦
This article is not relevant to the audiology field and carries no significance for hearing health professionals or researchers.
✦ Key Points ✦
- 01Narrative review covers recent advances in thyroid eye disease (TED) management.
- 02TED is an autoimmune condition associated with Graves' disease affecting the eyes.
- 03Article has no direct or indirect connection to audiology or hearing health.
- 04Published in Drugs in Context (doi: 10.7573/dic.2026-4-5).
✦ Research metadata ✦
- PMID
- 42741468
- DOI
- 10.7573/dic.2026-4-5.
- Journal
- Drugs in Context
- Publication type
- review
- Evidence level
- 5
- Population
- Patients with thyroid eye disease
- Intervention
- Recent advances in thyroid eye disease management
Primary outcomes
Management outcomes for thyroid eye disease